Conolidine’s analgesic consequences stem from its interaction with non-opioid pain pathways. Unlike opioids, which bind to µ-opioid receptors while in the central nervous technique, conolidine modulates alternate molecular targets. A Science Innovations review observed that conolidine interacts Along with the atypical chemokine receptor ACKR3/CXCR7, which regulates opioid peptide avai... https://peterl652ikl4.dailyblogzz.com/profile